Recommendations for the implementation of platelet autoantibody testing in clinical trials of immune thrombocytopenia

Journal of Thrombosis and Haemostasis

Volumn 10, Issue 4, 2012, Pages 695-697

  Arnold, D M ^a,b   Santoso, S ^c   Greinacher, A ^d  

^a MCMASTER UNIVERSITY   (Canada)

^b CANADIAN BLOOD SERVICES   (Canada)

^c Institute for Clinical Immunology and Transfusion Medicine   (Germany)

^d UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACID CITRATE DEXTROSE; ANTICOAGULANT AGENT; AUTOANTIBODY; CITRATE SODIUM; EDETIC ACID; FIBRINOGEN RECEPTOR ANTAGONIST; MONOCLONAL ANTIBODY; PLACEBO; RITUXIMAB; THROMBOCYTE ANTIBODY; THROMBOCYTE ANTIGEN;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNE THROMBOCYTOPENIA; BLOOD SAMPLING; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FOLLOW UP; IMMUNOASSAY; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; BLOOD PLATELETS; CLINICAL TRIALS AS TOPIC; CONSENSUS; EVIDENCE-BASED MEDICINE; HUMANS; INTEGRIN BETA3; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; SPECIMEN HANDLING; THROMBOCYTOPENIA;

EID: 84859178768     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2012.04664.x     Document Type: Article

References (10)

1. McMillan R, Wang L, Tani P. Prospective evaluation of the immunobead assay for the diagnosis of adult chronic immune thrombocytopenic purpura (ITP). J Thromb Haemost 2003; 1: 485-91.
2. Warner MN, Moore JC, Warkentin TE, Santos AV, Kelton JG. A prospective study of protein-specific assays used to investigate idiopathic thrombocytopenic purpura. Br J Haematol 1999; 104: 442-7.
3. Brighton TA, Evans S, Castaldi PA, Chesterman CN, Chong BH. Prospective evaluation of the clinical usefulness of an antigen-specific assay (MAIPA) in idiopathic thrombocytopenic purpura and other immune thrombocytopenias. Blood 1996; 88: 194-201.
4. Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 2011; 117: 4190-207.
5. Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: pathogenic and clinical diversity. Blood 2009; 113: 6511-21.
6. Wu GG, Kaplan C, Curtis BR, Pearson HA. Report on the 14th International Society of Blood Transfusion Platelet Immunology Workshop. Vox Sang 2010; 99: 375-81.
7. Kelton JG, Murphy WG, Lucarelli A, Garvey-Williams J, Santos A, Meyer R, Powers P. A prospective comparison of four techniques for measuring platelet-associated IgG. Br J Haematol 1989; 71: 97-105.
8. Kosugi S, Tomiyama Y, Honda S, Kato H, Kiyoi T, Kashiwagi H, Kurata Y, Matsuzawa Y. Platelet-associated anti-GPIIb-IIIa autoantibodies in chronic immune thrombocytopenic purpura recognizing epitopes close to the ligand-binding site of glycoprotein (GP) IIb. Blood 2001; 98: 1819-27.
9. McMillan R, Lopez-Dee J, Loftus JC. Autoantibodies to alpha(IIb)beta(3) in patients with chronic immune thrombocytopenic purpura bind primarily to epitopes on alpha(IIb). Blood 2001; 97: 2171-2.
10. Arnold DM, Heddle NM, Carruthers J, Cook DJ, Crowther MA, Meyer RM, Liu Y, Cook RJ, McLeod A, MacEachern JA, Mangel J, Anderson D, Vickars L, Tinmouth A, Schuh AC, Kelton JG. A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia. Blood 2012; 119: 1356-62.